Baxalta Incorporated Common Sto (BXLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BXLT | ARGX | ALNY | ||
| Company | Baxalta Incorporated Common Sto | Argenx Se ADR | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 46.27 | 625.60 | 244.63 | ||
| High | 46.52 | 630.16 | 244.64 | ||
| Low | 46.01 | 617.88 | 237.12 | ||
| Last | 46.02 | 628.32 | 242.26 | ||
| Change | -0.18 | +4.50 | -3.18 | ||
| % Change | -0.39% | +0.72% | -1.30% | ||
| Volume | 228,648,297 | 153,600 | 718,000 | ||
| 20-Day Average Volume | 24,994,385 | 281,920 | 681,000 | ||
| Previous Close | 46.20 | 623.82 | 245.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.79 | 617.64 | 249.42 | ||
| 20-Day Raw Stochastic | 91.45% | 61.59% | 35.82% | ||
| 20-Day Relative Strength | 68.35% | 59.92% | 41.72% | ||
| Weighted Alpha | +50.40 | +72.65 | +5.59 | ||
| Today's Opinion | N/A | 100% Buy | 24% Sell | ||
| Previous Opinion | N/A | 100% Buy | 8% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.70% since 05/26/16 | -0.68% since 12/16/24 | -0.71% since 12/16/24 | ||
| Low | 45.23 on 05/31/16 | 613.95 on 12/19/24 | 233.41 on 12/19/24 | ||
| High | 46.52 on 06/02/16 | 644.97 on 12/17/24 | 249.58 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +9.21% since 05/02/16 | +3.70% since 11/22/24 | -1.07% since 11/22/24 | ||
| Low | 40.67 on 05/06/16 | 601.64 on 11/26/24 | 233.41 on 12/19/24 | ||
| High | 46.52 on 06/02/16 | 644.97 on 12/17/24 | 258.12 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +15.34% since 03/02/16 | +18.89% since 09/23/24 | -10.88% since 09/23/24 | ||
| Low | 37.44 on 03/16/16 | 512.01 on 09/24/24 | 229.85 on 11/18/24 | ||
| High | 46.52 on 06/02/16 | 644.97 on 12/17/24 | 304.39 on 10/17/24 | ||
| 6-Month | |||||
| %Chg | +29.16% since 12/02/15 | +59.28% since 06/21/24 | +46.20% since 06/21/24 | ||
| Low | 34.50 on 12/04/15 | 428.76 on 06/28/24 | 209.23 on 06/24/24 | ||
| High | 46.52 on 06/02/16 | 644.97 on 12/17/24 | 304.39 on 10/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,579,550 | 37,930,424 | 31,246,938 | ||
| Shares Outstanding, K | 683,080 | 60,368 | 128,981 | ||
| Annual Sales | 6,148,000,000 | 1,268,590,000 | 1,828,290,000 | ||
| Annual Net Income | 956,000,000 | -295,050,000 | -440,240,000 | ||
| Last Quarter Sales | 1,548,000,000 | 588,880,000 | 500,920,000 | ||
| Last Quarter Net Income | 145,000,000 | 91,410,000 | -111,570,000 | ||
| 60-Month Beta | N/A | 0.59 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 04/28/16 | 1.39 on 10/31/24 | -0.50 on 10/31/24 | ||
| Latest Earnings Date | 04/28/16 | 10/31/24 | 10/31/24 | ||
| Most Recent Dividend | 0.070 on 03/08/16 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/08/16 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.10 | 0.00 | 0.00 | ||